The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Lupin Australia Pty Limited
Regulatory activities for this sponsor.
Loading...
Sponsor content
550 result(s) found, displaying 51 to 60
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SUGAMMADEX LUPIN sugammadex (as sodium) 200 mg/2 mL solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SUGAMMADEX LAPL sugammadex (as sodium) 500 mg/5 mL solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SUGAMMADEX LUPIN sugammadex (as sodium) 500 mg/5 mL solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SUGAMMADEX LAPL sugammadex (as sodium) 200 mg/2 mL solution for injection vial.
-
Cancellation by sponsorRequested by Lupin Australia Pty Limited
-
Cancellation by sponsorRequested by Lupin Australia Pty Limited
-
Cancellation by sponsorRequested by Lupin Australia Pty Limited
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FENOFIBRATE GH fenofibrate 145 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FENOFIBRATE GH fenofibrate 48 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FENOFIBRATE LUPIN fenofibrate 48 mg film-coated tablet blister pack.